Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 424509, 10 pages
http://dx.doi.org/10.1155/2014/424509
Research Article

Identifying the Gene Signatures from Gene-Pathway Bipartite Network Guarantees the Robust Model Performance on Predicting the Cancer Prognosis

1Biogas Institute of Ministry of Agriculture, Chengdu 610041, China
2College of Chemistry, Sichuan University, Chengdu 610064, China

Received 16 April 2014; Revised 21 June 2014; Accepted 24 June 2014; Published 14 July 2014

Academic Editor: Mingyue Zheng

Copyright © 2014 Li He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. J. van't Veer, H. Dai, M. J. van de Vijver et al., “Gene expression profiling predicts clinical outcome of breast cancer,” Nature, vol. 415, no. 6871, pp. 530–536, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. E. L. Leung, Z.-W. Cao, Z.-H. Jiang, H. Zhou, and L. Liu, “Network-based drug discovery by integrating systems biology and computational technologies,” Briefings in Bioinformatics, vol. 14, no. 4, pp. 491–505, 2013. View at Google Scholar
  3. F. Zhan, J. Hardin, B. Kordsmeier et al., “Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells,” Blood, vol. 99, no. 5, pp. 1745–1757, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. K. R. Hess, K. Anderson, W. F. Symmans et al., “Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer,” Journal of Clinical Oncology, vol. 24, no. 26, pp. 4236–4244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Shaughnessy Jr., F. Zhan, B. E. Burington et al., “Avalidated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1,” Blood, vol. 109, no. 6, pp. 2276–2284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. H. S. Phillips, S. Kharbanda, R. Chen et al., “Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis,” Cancer Cell, vol. 9, no. 3, pp. 157–173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Lee, A. Scheck, T. Cloughesy et al., “Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age,” BMC Medical Genomics, vol. 1, no. 1, article 52, 2008. View at Publisher · View at Google Scholar
  8. A. Oberthuer, F. Berthold, P. Warnat et al., “Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification,” Journal of Clinical Oncology, vol. 24, no. 31, pp. 5070–5078, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Shi, G. Campbell, W. D. Jones et al., “The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models,” Nature Biotechnology, vol. 28, no. 8, pp. 827–838, 2010. View at Publisher · View at Google Scholar
  10. M. A. van Driel, K. Cuelenaere, P. P. C. W. Kemmeren, J. A. M. Leunissen, and H. G. Brunner, “A new web-based data mining tool for the identification of candidate genes for human genetic disorders,” European Journal of Human Genetics, vol. 11, no. 1, pp. 57–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Aerts, D. Lambrechts, S. Maity et al., “Gene prioritization through genomic data fusion,” Nature Biotechnology, vol. 24, no. 5, pp. 537–544, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Goh, M. E. Cusick, D. Valle, B. Childs, M. Vidal, and A. Barabási, “The human disease network,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 21, pp. 8685–8690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Wang, A. Lenferink, and M. O'Connor-McCourt, “Genetic studies of diseases - Cancer systems biology: Exploring cancer-associated genes on cellular networks,” Cellular and Molecular Life Sciences, vol. 64, no. 14, pp. 1752–1762, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Moreau and L. C. Tranchevent, “Computational tools for prioritizing candidate genes: boosting disease gene discovery,” Nature Reviews Genetics, vol. 13, no. 8, pp. 523–536, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. I. F. Bass, A. Diallo, and J. Nelson, “Corrigendum: using networks to measure similarity between genes: association index selection,” Nature Methods, vol. 11, no. 3, pp. 349–349, 2014. View at Google Scholar
  16. P. Hernández, J. Huerta-Cepas, D. Montaner et al., “Evidence for systems-level molecular mechanisms of tumorigenesis,” BMC Genomics, vol. 8, article 185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. F. M. Lopes and J. Cesar, “Gene expression complex networks: synthesis, identification, and analysis,” Journal of Computational Biology, vol. 18, no. 10, pp. 1353–1367, 2011. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  18. O. Rozenblatt-Rosen, R. C. Deo, M. Padi et al., “Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins,” Nature, vol. 487, no. 7408, pp. 491–495, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Wang, J. Gu, J. Yuan, R. Tao, Y. Li, and S. Li, “Inferring pathway crosstalk networks using gene set co-expression signatures,” Molecular BioSystems, vol. 9, no. 7, pp. 1822–1828, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Jiang, X. Li, S. Q. Rao et al., “Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements,” BMC Systems Biology, vol. 2, article 72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Li, K. Zhang, J. Lee, S. Cordes, D. P. Davis, and Z. Tang, “Discovering cancer genes by integrating network and functional properties,” BMC Medical Genomics, vol. 2, no. 1, article 61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Milenković, V. Memišević, A. K. Ganesan, and N. Pršulj, “Systems-level cancer gene identification from protein interaction network topology applied to melanogenesis-related functional genomics data,” Journal of the Royal Society Interface, vol. 7, no. 44, pp. 423–437, 2010. View at Google Scholar
  23. G. Östlund, M. Lindskog, and E. L. L. Sonnhammer, “Network-based identification of novel cancer genes,” Molecular and Cellular Proteomics, vol. 9, no. 4, pp. 648–655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Agnelli, M. Forcato, F. Ferrari et al., “The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myeloma,” Clinical Cancer Research, vol. 17, no. 23, pp. 7402–7412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Ahn, Y. Yoon, C. Park, E. Shin, and S. Park, “Integrative gene network construction for predicting a set of complementary prostate cancer genes,” Bioinformatics, vol. 27, no. 13, pp. 1846–1853, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Chen, J. Xuan, R. B. Riggins, R. Clarke, and Y. Wang, “Identifying cancer biomarkers by network-constrained support vector machines,” BMC Systems Biology, vol. 5, article 161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. X. Wang, G. Chen, M. Li, and Y. Pan, “Integration of breast cancer gene signatures based on graph centrality,” BMC Systems Biology, vol. 5, no. 3, article S10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. D'Antonio, V. Pendino, S. Shruti, and F. D. Ciccarelli, “Network of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genes,” Nucleic Acids Research, vol. 40, no. 1, pp. D978–D983, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Roy, C. Winter, Z. Isik, and M. Schroeder, “Network information improves cancer outcome prediction,” Briefings in Bioinformatics, 2012. View at Publisher · View at Google Scholar
  30. C. Staiger, S. Cadot, R. Kooter et al., “A critical evaluation of network and pathway-based classifiers for outcome prediction in breast cancer,” PLoS ONE, vol. 7, no. 4, Article ID e34796, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Winter, G. Kristiansen, S. Kersting et al., “Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes,” PLoS Computational Biology, vol. 8, no. 5, Article ID e1002511, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Wu, D. D'Argenio, S. Asgharzadeh, and T. Triche, “TARGETgene: a tool for identification of potential therapeutic targets in cancer,” PLoS ONE, vol. 7, no. 8, Article ID e43305, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Wu and L. Stein, “A network module-based method for identifying cancer prognostic signatures,” Genome Biology, vol. 13, no. 12, article R112, 2012. View at Google Scholar
  34. Y. Chen, J. Hao, W. Jiang et al., “Identifying potential cancer driver genes by genomic data integration,” Scientific Reports, vol. 3, p. 3538, 2013. View at Google Scholar
  35. Y. Nie and J. Yu, “Mining breast cancer genes with a network based noise-tolerant approach,” BMC Systems Biology, vol. 7, article 49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Fröhlich, “Including network knowledge into Cox regression models for biomarker signature discovery,” Biometrical Journal, vol. 56, no. 2, pp. 287–306, 2014. View at Google Scholar
  37. L. Jiang, L. Huang, Q. Kuang et al., “Improving the prediction of chemotherapeutic sensitivity of tumors in breast cancer via optimizing the selection of candidate genes,” Computational Biology and Chemistry, vol. 49, pp. 71–78, 2014. View at Google Scholar
  38. A. Chaiboonchoe, S. Samarasinghe, D. Kulasiri, and K. Salehi-Ashtiani, “Integrated analysis of gene network in childhood leukemia from microarray and pathway databases,” BioMed Research International, vol. 2014, Article ID 278748, 7 pages, 2014. View at Publisher · View at Google Scholar
  39. K. H. Metzeler, M. Hummel, C. D. Bloomfield et al., “An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia,” Blood, vol. 112, no. 10, pp. 4193–4201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Li, N. Zhang, Z. Liu, and G. Zhao, “Based on bipartite graph label gene extraction algorithm of network structure,” International Journal of Biology, vol. 3, no. 4, p. 64, 2011. View at Google Scholar
  41. P. Holme, F. Liljeros, C. R. Edling, and B. J. Kim, “Network bipartivity,” Physical Review E: Statistical, Nonlinear, and Soft Matter Physics, vol. 68, no. 5, part 2, Article ID 056107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Zhou, J. Ren, M. Medo, and Y. Zhang, “Bipartite network projection and personal recommendation,” Physical Review E, vol. 76, no. 4, Article ID 046115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. V. N. Vapnik, The Nature of Statistical Learning Theory, Springer, New York, NY, USA, 1995.
  44. V. N. Vapnik, Statistical Learning Theory, Wiley, New York, NY, USA, 1998.
  45. C. Chang and C. Lin, “LIBSVM: a Library for support vector machines,” ACM Transactions on Intelligent Systems and Technology, vol. 2, no. 3, article 27, 2011. View at Publisher · View at Google Scholar · View at Scopus